Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations

Peer Review reports

Original Submission
8 Nov 2017	Submitted	Original manuscript
18 Apr 2018	Reviewed	Reviewer Report - Robert Reed
22 Jun 2018	Reviewed	Reviewer Report - Lehana Thabane
18 Jul 2018	Author responded	Author comments - Juthaporn Cowan
Resubmission - Version 2
18 Jul 2018	Submitted	Manuscript version 2
Publishing
31 Jul 2018	Editorially accepted
11 Aug 2018	Article published	10.1186/s40814-018-0327-z

Back to article page